UpHealth, Inc.: Nasdaq/NYSE listing notice — UpHealth delisted from NYSE, hearing April 17; Thrasys ceases operations; debt trustee changes

UpHealth, Inc.

NYSE suspended trading Dec 12, 2023; stock now OTC under "UPHL". Hearing before CFR set for April 17, 2024 to appeal delisting.
Thrasys closed transition agreements with L.A. Care, EmpiRx Health, and Alameda County on Dec 28, 2023; Thrasys now has no operations.
Wilmington Trust resigned as trustee for 6.25% Convertible Notes due 2026; BNY Mellon appointed successor effective Jan 11, 2024.
Company warns of substantial doubt about going concern if delisting leads to acceleration of debt; sale of Cloudbreak is key to resolve.

item 1.01 item 3.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

UpHealth, Inc. received a nyse delisting notice notice regarding market value (rules 802.01B).

Exchange: nyse
Notice: delisting notice
Deficiency: market value
Rules: 802.01B

Exact text from the filing

December 11, 2023, the Company received written notice from the staff of NYSE Regulation (the “ Staff ”) that, because the Company was no longer in compliance with the continued listing standard under Section 802.01B of the NYSE Listed Company Manual requiring listed companies to maintain an average global market capitalization over a consecutive 30 trading day period of at least $15,000,000 (the “ Market Capitalization Rule ”), the Staff has commenced proceedings to delist the common stock, par value $0.0001 per share, of the Company (the “ Common Stock ”), from the New York Stock Exchange (t

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001770141-24-000003

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.